ZoomInfo vs Cognism for Reaching the Real Training Budget Owner

A training manager can champion your program enthusiastically and still have no authority to sign a company-wide certification contract. That authority usually sits with an HR or L&D director, sometimes a CFO's office if the spend crosses a budget threshold, and your champion may not fully understand where that line sits inside their own company.

A sales-intelligence tool's real job here is not finding more leads, it is showing you the reporting line above the person already excited about your program.

Once you can see who your champion reports to, and who that person reports to, you can build a business case aimed at the actual decision-maker instead of hoping your champion carries it upward alone. ZoomInfo's hierarchy view also flags recent leadership changes, a new Chief People Officer is often actively reviewing vendor contracts in their first two quarters, which can turn a stalled deal into a live one.

This is the single most useful application of the tool in enterprise training sales: not volume, but accuracy about who signs.

A domestic training pilot that goes well often needs to expand into a multinational client's other regions, and that is where Cognism's European contact data and consent-first outreach earn their keep. Reaching an L&D director in a company's German or French subsidiary by phone, with numbers that clear consent requirements, tends to work better than a cold email that a US-based rep would default to otherwise.

For a training business selling only within the United States, this advantage is mostly theoretical and not worth paying for yet.

Say your champion, a training manager, has gone quiet for three weeks after an enthusiastic pilot. Pull the org chart, identify their manager and the L&D director above that role, and send a short note to the director referencing the pilot's specific results rather than a generic reintroduction. This approach works because it treats the stall as an approval-chain problem, which it almost always is, rather than a loss of interest, which it rarely is.

A cold reintroduction to the same champion, by contrast, usually gets the same silence a second time.

Escalate past a stalled champion in this order:

1. Treat a champion who went quiet after an enthusiastic pilot as a possible authority gap, not a sign that interest has cooled.
2. Pull the org chart and identify the champion's manager and the L&D director above that role.
3. Ask the champion to make the introduction, framing it as making their internal case easier rather than bypassing them.
4. Send the director a short note that references the pilot's specific results.

Close keeps the approval-chain contacts, the champion, their manager, and the budget owner, visible in one place so a rep can see the whole account at a glance instead of losing track of who was contacted when. lemlist handles the sequence to the newly identified budget owner, spaced so it reads as a considered follow-up rather than a mass email that happened to land in their inbox.

A stalled training deal sometimes has nothing to do with your program and everything to do with a leadership change you have not noticed yet. When a Chief People Officer or VP of Talent leaves, vendor contracts they were reviewing typically freeze until the replacement settles in, reviews existing commitments, and decides what to keep.

Watching for that turnover, rather than assuming silence means lost interest, changes how you follow up. ZoomInfo's leadership-change alerts flag exactly this kind of event, and the right move is usually patience paired with a brief, low-pressure check-in rather than an aggressive escalation that a brand-new executive has no context to evaluate.

Once a new leader settles in, that is often the better moment to reintroduce your program with fresh results from the pilot, rather than treating the original champion's silence as a final answer. Track leadership changes at every active account, not just the accounts already showing signs of stalling, since the pattern is easier to act on early than to diagnose after months of silence.